ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

AbbVie 



      U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.


 Key Statistics


Email:
Ownership: Public

Web Site: AbbVie
Employees:
Symbol: ABBV
 



Industry
Pharmaceutical






 Company News
AbbVie (ABBV) Reports Fourth-Quarter And Full-Year 2014 Financial Results 1/30/2015 10:11:30 AM
After Gilead Sciences, Inc. (GILD)-AbbVie (ABBV)'s Hep C Price War, Express Scripts Inc. Eyes Cancer Meds Next 1/23/2015 6:40:49 AM
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK) 1/21/2015 4:06:07 PM
New AbbVie (ABBV) Innovation Center to Employ Students for Discovery of Cutting-Edge Therapies 1/21/2015 11:13:50 AM
Enanta Pharmaceuticals, Inc. Announces European Commission (EC) Grants Marketing Authorizations For AbbVie (ABBV)’s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets)... 1/16/2015 9:50:01 AM
AbbVie (ABBV) To Host Fourth-Quarter And Full-Year 2014 Earnings Conference Call 1/16/2015 9:46:35 AM
AbbVie (ABBV) Announces U.S. FDA Approval Of DUOPA™ (carbidopa and levodopa) Enteral Suspension For The Treatment Of Motor Fluctuations In Patients With Advanced Parkinson's Disease 1/16/2015 9:28:16 AM
European Commission (EC) Grants Marketing Authorizations For AbbVie (ABBV)'s VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) For The Treatment Of Chronic Hepatitis C 1/16/2015 7:55:05 AM
J.P. Morgan: AbbVie (ABBV) Getting "Very Compelling" Exclusive Offers for Viekira Pak, Says CFO 1/14/2015 4:23:51 PM
AbbVie (ABBV) Announces U.S. FDA Approval Of DUOPA™ (carbidopa and levodopa) Enteral Suspension For The Treatment Of Motor Fluctuations In Patients With Advanced Parkinson's Disease 1/12/2015 8:23:02 AM
12345678910...